Treatment Implications Associated With Cannabis and Tobacco Co-use
- PDF / 347,375 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 63 Downloads / 158 Views
CANNABIS ADDICTION (B SHERMAN AND A MCRAE-CLARK, SECTION EDITORS)
Treatment Implications Associated With Cannabis and Tobacco Co-use Erin A. McClure 1,2 & Rachel A. Rabin 3 & Dustin C. Lee 4 & Chandni Hindocha 5,6,7 Accepted: 14 September 2020 # Springer Nature Switzerland AG 2020
Abstract Purpose of Review The goal of this article is to summarize the treatment-focused literature on cannabis and tobacco co-use and the treatment implications of co-use. This review will focus on the following: (1) the impact of co-use on cessation outcomes, (2) compensatory use/substitution of the non-treated substance among co-users, and (3) treatment interventions to address co-use. This article will highlight the limitations to co-use captured in the literature and offer considerations and directives for co-use research and treatment moving forward. Recent Findings The degree to which co-use affects cessation for a single, targeted substance remains in question, as the literature is largely mixed. Cannabis treatment trials are better equipped to answer these questions given that they do not typically exclude tobacco users. While the relationship between tobacco use and poorer cannabis outcomes appears to have some evidence, the reverse relationship (cannabis use affecting tobacco outcomes) is not consistently supported. Summary The co-use of cannabis and tobacco and its impact on single substance cessation and/or compensatory substance use during cessation is generally overlooked in treatment trials, while interventions to address both substances are rare. Capturing couse adds burden for researchers, clinicians, and participants, but is warranted given the prevalence of co-use and a rapidly changing cannabis and tobacco regulatory environment, which may further complicate co-occurring substance use. Co-users are a heterogeneous population; trials focused on co-users, in addition to better data capture and consistent terminology, will aid in an understanding of nuanced patterns of co-use critical to inform treatment interventions. Keywords Cannabis . Tobacco . Co-use . Poly-substance use . Treatment . Cessation . Substitution
This article is part of the Topical Collection on Cannabis Addiction * Erin A. McClure [email protected]; https://orcid.org/0000-0001-9744-7818 Rachel A. Rabin https://orcid.org/0000-0002-6530-0288 Dustin C. Lee https://orcid.org/0000-0002-4818-9733
3
Department of Psychiatry, McGill University and The Douglas Mental Health Institute, Montreal, Canada
4
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
5
Clinical Psychopharmacology Unit, Department of Clinical, Educational & Health Psychology, University College London, Faculty of Brain Sciences, University College London, London, UK
6
Translational Psychiatry Research Group, Research Department of Mental Health Neuroscience, Division of Psychiatry, Faculty of Brain Sciences, University College London, London, UK
7
University College Hospital National Institute of Health Research (NIH
Data Loading...
